{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:37:24Z","timestamp":1794710244433,"version":"4.9.1"},"reference-count":30,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2022,11,28]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>We conducted a meta-analysis of randomised controlled trials (RCTs) of implantable haemodynamic monitoring (IHM)-guided care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>PubMed and Ovid MEDLINE were searched for RCTs of IHM in patients with heart failure (HF). Outcomes were examined in total (first and recurrent) event analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Five trials comparing IHM-guided care with standard care alone were identified and included 2710 patients across ejection fraction (EF) ranges. Data were available for 628 patients (23.2%) with heart failure with preserved ejection fraction (HFpEF) (EF \u226550%) and 2023 patients (74.6%) with heart failure with a reduced ejection fraction (HFrEF) (EF &lt;50%). Chronicle, CardioMEMS and HeartPOD IHMs were used. In all patients, regardless of EF, IHM-guided care reduced total HF hospitalisations (HR 0.74, 95%\u2009CI 0.66 to 0.82) and total worsening HF events (HR 0.74, 95%\u2009CI 0.66 to 0.84). In patients with HFrEF, IHM-guided care reduced total worsening HF events (HR 0.75, 95%\u2009CI 0.66 to 0.86). The effect of IHM-guided care on total worsening HF events in patients with HFpEF was uncertain (fixed-effect model: HR 0.72, 95% CI 0.59 to 0.88; random-effects model: HR 0.60, 95% CI 0.32 to 1.14). IHM-guided care did not reduce mortality (HR 0.92, 95% CI 0.71 to 1.20). IHM-guided care reduced all-cause mortality and total worsening HF events (HR 0.80, 95%\u2009CI 0.72 to 0.88).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In patients with HF across all EFs, IHM-guided care reduced total HF hospitalisations and worsening HF events. This benefit was consistent in patients with HFrEF but not consistent in HFpEF. Further trials with pre-specified analyses of patients with an EF of \u226550% are required.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42021253905.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2022-321885","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T13:21:06Z","timestamp":1671110466000},"page":"823-831","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-7445","authenticated-orcid":false,"given":"James P","family":"Curtain","sequence":"first","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M Y","family":"Lee","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John JV","family":"McMurray","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy S","family":"Gardner","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S","family":"Jhund","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"2025092022493805000_109.11.823.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025092022493805000_109.11.823.2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","article-title":"Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial","volume":"398","author":"Lindenfeld","year":"2021","journal-title":"Lancet"},{"key":"2025092022493805000_109.11.823.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"2025092022493805000_109.11.823.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.6.706"},{"key":"2025092022493805000_109.11.823.5","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181c1ea43"},{"key":"2025092022493805000_109.11.823.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39063.689375.55"},{"key":"2025092022493805000_109.11.823.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d2090"},{"key":"2025092022493805000_109.11.823.8","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2025092022493805000_109.11.823.9","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2115"},{"key":"2025092022493805000_109.11.823.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2011.00247.x"},{"key":"2025092022493805000_109.11.823.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2016.09.012","article-title":"Hemodynamic monitoring in advanced heart failure: results from the LAPTOP-HF trial","volume":"22","author":"Abraham","year":"2016","journal-title":"J Card Fail"},{"key":"2025092022493805000_109.11.823.12","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1016\/j.csda.2008.04.009","article-title":"Comparison of the Andersen\u2013Gill model with Poisson and negative binomial regression on recurrent event data","volume":"52","author":"Jahn-Eimermacher","year":"2008","journal-title":"Comput Stat Data Anal"},{"key":"2025092022493805000_109.11.823.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.12.007"},{"key":"2025092022493805000_109.11.823.14","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/eurheartj\/ehac114","article-title":"The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic","volume":"43","author":"Zile","year":"2022","journal-title":"Eur Heart J"},{"key":"2025092022493805000_109.11.823.15","unstructured":"Abraham WT . Cumulative hazard rate for heart failure hospitalization over 12 months in LAPTOP-HF. ESC\/HFA heart failure Congress 2017; Paris: European Society of cardiology \/ heart failure association 2017."},{"key":"2025092022493805000_109.11.823.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.10.061"},{"key":"2025092022493805000_109.11.823.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00723-0"},{"key":"2025092022493805000_109.11.823.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60101-3"},{"key":"2025092022493805000_109.11.823.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229"},{"key":"2025092022493805000_109.11.823.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2008.07.235"},{"key":"2025092022493805000_109.11.823.21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.783910"},{"key":"2025092022493805000_109.11.823.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2011.01.010"},{"key":"2025092022493805000_109.11.823.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.109.923300"},{"key":"2025092022493805000_109.11.823.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077"},{"key":"2025092022493805000_109.11.823.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303"},{"key":"2025092022493805000_109.11.823.26","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/CIRCULATIONAHA.121.053659","article-title":"Dapagliflozin and recurrent heart failure hospitalizations in heart failure with reduced ejection fraction: an analysis of DAPA-HF","volume":"143","author":"Jhund","year":"2021","journal-title":"Circulation"},{"key":"2025092022493805000_109.11.823.27","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1908655"},{"key":"2025092022493805000_109.11.823.28","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025092022493805000_109.11.823.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190"},{"key":"2025092022493805000_109.11.823.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906431"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2022-321885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T05:49:43Z","timestamp":1758433783000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2022-321885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,5,15]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/heartjnl-2022-321885"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2022-321885","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]}}}